Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2017-04-14 Proxy Solicitation & In…
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text indicates it is an amendment or additional materials to a previously filed definitive proxy statement, specifically correcting a typographical error and confirming the date of the annual meeting of shareholders. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document is not the proxy statement itself but additional materials related to it. Given the nature of the filing and the SEC form type, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and it is not a full report but an amendment to proxy materials, so it is not an Annual Report or other financial report. Confidence is high due to clear identification of the form and content.
2017-04-14 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a proxy solicitation for an annual shareholders' meeting. It includes information about the annual meeting date, proposals to be voted on, board recommendations, and instructions for voting. It does not contain the actual proxy statement or annual report itself but rather additional proxy materials. The presence of terms like 'Proxy Statement Pursuant to Section 14(a)', 'Definitive Additional Materials', and detailed voting instructions confirms this is proxy solicitation material. According to the filing definitions, proxy solicitation materials are classified under Proxy Solicitation & Information Statement (PSI). The document length (7019 characters) and content confirm it is not a brief announcement or a full annual report but proxy materials. Therefore, the correct classification is PSI with high confidence.
2017-04-13 English
DEF 14A
Proxy Solicitation & Information Statement
2017-04-13 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-21 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-21 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.